Skip to content

Opening book details…

About this Medicine article

111P Advanced non-small cell lung cancer with PD-L1≥50%: Pembrolizumab alone or combined with chemotherapy by Han, B. (author);Han, B. (author);Zhang, B. (author);Hu, M. (author);Wang, Y. (author);Yang, Z. (author);Zhang, W. (author) is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Han, B. (author);Han, B. (author);Zhang, B. (author);Hu, M. (author);Wang, Y. (author);Yang, Z. (author);Zhang, W. (author)
Publisher
Elsevier BV
Published
2021
Field
Medicine (Health Sciences)

More by Han, B. (author);Han, B. (author);Zhang, B. (author);Hu, M. (author);Wang, Y. (author);Yang, Z. (author);Zhang, W. (author)

Browse all works by Han, B. (author);Han, B. (author);Zhang, B. (author);Hu, M. (author);Wang, Y. (author);Yang, Z. (author);Zhang, W. (author)